AI-Enhanced Smartphone Technology Could Help Detect Abnormal Lung Sounds in Children
Researchers are adapting artificial intelligence to support respiratory assessment where specialist equipment is limited.
Medical Xpress reported on 16 October that researchers developed an adapted AI approach for smartphone-based detection of abnormal lung sounds in children. The technology could eventually help support respiratory assessment in settings where access to clinicians or diagnostic tools is limited.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Respiratory illnesses are a significant cause of illness in children. Doctors often listen to the lungs with a stethoscope to identify wheezing, crackles or other abnormal sounds that may help guide further examination. An AI-assisted smartphone tool aims to analyse recorded lung sounds and identify patterns that could suggest a respiratory problem. If validated, such technology might support screening, remote consultations or early identification of children who need an in-person medical assessment. However, a sound-analysis tool is not equivalent to a complete clinical examination. Background noise, recording quality, a child's movement and differences between respiratory conditions can affect accuracy. Researchers must establish how well the system performs across age groups and healthcare settings before it can be relied upon in routine care. Parents should not use an app to rule out serious illness. A child with difficulty breathing, bluish lips, severe drowsiness, dehydration or rapidly worsening symptoms needs urgent medical assessment.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
